20-50x ROI, +45% lift in adherence to target, 90% rep adoption, live across US + EU.

Healthcare and pharma teams work across CRM, BI, access, pricing, and patient-support systems. Lily brings the work into one secure, auditable surface, follows your rules, and keeps the existing systems as the source of record.
One compliant surface. No shadow IT. AI that works inside your stack.
Veeva, SAP, Dynamics, BI, hubs, pricing tools.
Account intelligence, pricing, access, next best action.
Payer/claims risk, pricing guidance, target priorities.
Field, access, patient-support, and hub teams stay in sync.
BD, in-licensing, and commercial actions in hours, not weeks.
Consolidates BI, account intelligence, and pricing into a single rep-facing surface, with payer/claims risk and next best action per target.
Aligns commercial, access, and patient data so gaps surface early, and stitches market data into one view for BD - HIPAA/BAA-ready by default.
90% rep adoption - far above the 20-30% CRM norm - with new reps productive in their first week, not after months of ramp.
+45% adherence to target and 20-50x ROI on the Kedrion Biopharma deployment, live across both US and EU and returning ~1.5 FTEs per 25 reps.
Every connection runs under your governance: BAA, audit trails, no shadow IT.
Veeva, SAP, Dynamics, Azure, and your BI feed one auditable surface, nothing duplicated.
20-50x ROI, +45% lift in adherence to target, 90% rep adoption, live across US + EU.

Pricing automation with supplier price-list ingestion, anomaly detection, and JD Edwards Price Master writeback; supporting a $75-100M cost-savings target.

Email routing/classification + PO/quote automation with EDI 855/856 and phone intake; duplicate POs cut from ~2,500 to ~100.

Behind this solution: Lily, the AI Forward Deployed Engineer, working on the platform Lily builds on, delivered through forward deployed engineering.